Helle-Brit Fiebrich, Sophie J. van Asselt, Adrienne H

Slides:



Advertisements
Similar presentations
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
Advertisements

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Gastric cancer Critical Reviews in Oncology / Hematology
Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 
Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,
Michalis Aristophanous, Yue Yong, Jeffrey T. Yap, Joseph H
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.
Volume 75, Issue 1, Pages (January 2012)
Novel targets in gastric and esophageal cancer
Critical Reviews in Oncology / Hematology
CT and PET imaging in non-small cell lung cancer
Nicoletta Colombo, Martin Gore 
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,
Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis 
The case for wider use of recombinant factor VIII concentrates
P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency 
Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature  Omar Abdel-Rahman,
Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead  J. Carlijn Van Gaal, Eveline S.J.M. De Bont, Suzanne.
Simultaneous positron emission tomography (PET) assessment of metabolism with 18F- fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine.
Genistein: Its role in metabolic diseases and cancer
Role of computed tomography on large B-cell non-Hodgkin’s lymphoma follow-up and the risk of radiation-induced neoplasm: A retrospective cohort study 
Genomic analysis: Toward a new approach in breast cancer management
Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review.
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)  Giorgio Arcangeli,
Abhimanyu Ghose, Ria Kundu, Tahir Latif 
Hugo J.A. Adams, Rutger A.J. Nievelstein, Thomas C. Kwee  Blood Reviews 
Rohit Venkatesan, Amir Salam, Issam Alawin, Maurice Willis 
Olfa Baroudi, Amel Benammar-elgaaied 
Peyman Hadji, Robert Coleman, Michael Gnant 
Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward 
Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging  Doenja M.J. Lambregts,
Critical Reviews in Oncology / Hematology
Primary renal carcinoid: Treatment and prognosis
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario  Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello  Critical.
Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of.
Jenny Dave, MS, Mark A. Ahlman, MD, Benjamin N. Lockshin, MD, David A
[18F] 3-deoxy-3′-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-d-glucose positron emission.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Yuji Nakamoto  Clinical Lymphoma, Myeloma and Leukemia 
Positron Emission Tomography in Lung Cancer
Foreign-body granuloma mimicking post-chemotherapy residual seminoma: A case of true-negative findings using diffusion-weighted whole-body magnetic resonance.
Pancreatic Cancer—Could It Be that Simple
Height Loss and Generalized Pain in a 35-year-old Man
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Zeynep Eroglu, MD, Jae Kim, MD, Sharon Wilczynski, MD, PhD, Warren A
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer 
Sharon L. Hammond, MD, David L. Greco, MD, Albert T
Computed diffusion weighted imaging (cDWI) and voxelwise-computed diffusion weighted imaging (vcDWI) for oncologic liver imaging: A pilot study  Ferdinand.
Infected splenic artery aneurysm with associated splenic abscess formation secondary to bacterial endocarditis: Case report and review of the literature 
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Phosphoglyceride crystal deposition disease mimicking a malignant tumor  Hiroyuki Tokue, Masayuki Ebara, Ryosuke Takahashi, Azusa Tokue, Yoshito Tsushima 
Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation.
Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes
Gross tumour delineation on computed tomography and positron emission tomography- computed tomography in oesophageal cancer: A nationwide study  M.E. Nowee,
Salvage Operation in Case of Oligometastatic Disease
Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced.
Gastrointestinal imaging: Endoscopic ultrasound
Leiomyosarcoma of the splenic vein
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
David Montero, Agnès Vinet, Christian K. Roberts 
Axillary Mass and Hypercalcemia: The Value of a Physical Examination
Splenic vein aneurysm: Is it a surgical indication?
What is type 2 diabetes? Medicine
Matthew Reichert, MD, Eric S. Bensadoun, MD 
FDG imaging of a pulmonary artery sarcoma
Fig. 1.Representative images of 18F-FDG PET-CT and immunohistochemical staining for TILs. (A) Whole-body 18F-FDG PET image demonstrates increased FDG uptake.
Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy  Matthew S. Block, MD, PhD, Robert Vassallo,
Expansion rates and outcomes for iliac artery aneurysms
Presentation transcript:

Tailored imaging of islet cell tumors of the pancreas amidst increasing options  Helle-Brit Fiebrich, Sophie J. van Asselt, Adrienne H. Brouwers, Hendrik M. van Dullemen, Milan E.J. Pijl, Philip H. Elsinga, Thera P. Links, Elisabeth G.E. de Vries  Critical Reviews in Oncology / Hematology  Volume 82, Issue 2, Pages 213-226 (May 2012) DOI: 10.1016/j.critrevonc.2011.05.006 Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Results of endoscopic ultrasound presented in a Forest plot analysis. On the left side of this plot the reference of the study is mentioned, on the right side sensitivities from literature data are provided with their calculated confidence intervals and number of patients. Results are clustered per imaging indication. Within the different groups studies are clustered per tumor subtype and according to year of publishing. 95% CI: 95% Confidence Interval. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Patient with a small, 0.6×0.9cm, metastasized glucagonoma, presenting with diabetes mellitus, jaundice and a rash. (A) Endoscopic ultrasound, showing the pancreatic tumor (arrow). On the left adjacent to the tumor the splenic artery (s.a.) and the hepatocaval confluence (c) are visible. (B) The lesion is not visualized by computer tomography. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 3 Illustration of yield of different imaging techniques in a patient with a metastasized non-functioning islet cell tumor, 2×2.7cm. A lesion in the pancreas and liver metastases are visualized on all imaging techniques. (A) Computer tomography shows precise anatomical location of the pancreatic lesion and of multiple liver metastases. (B) Somatostatin receptor scintigraphy shows tracer uptake in pancreas and liver lesions. (C) 11C-HTP PET demonstrates uptake in the pancreas and multiple liver metastases. (D) 18F-DOPA PET shows lesions in the pancreas and liver, more lesions were observed with 11C-HTP PET. (E) A fusion image of 11C-HTP PET and CT demonstrates multiple liver metastases. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 4 Results of computer tomography in publications published between 2003 and January 2010 and all MDCT studies presented in a Forest plot analysis. On the left side of this plot the reference of the study is mentioned, on the right side sensitivities from literature data are provided with their calculated confidence intervals and number of patients. Results are clustered per imaging indication. Within the different groups studies are clustered per tumor subtype and according to year of publishing. 95% CI: 95% Confidence Interval. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 5 Results of magnetic resonance imaging presented in a Forest plot analysis. On the left side of this plot the reference of the study is mentioned, on the right side sensitivities from literature data are provided with their calculated confidence intervals and number of patients. Results are clustered per imaging indication. Within the different groups studies are clustered per tumor subtype and according to year of publishing. 95% CI: 95% Confidence Interval. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 6 Schematic depiction of the different metabolic pathways by which neuroendocrine tumors can be visualized using nuclear medicine imaging techniques. This can be receptor based techniques and techniques which use the metabolic properties of these tumors. 11C-5-HTP: 11C-5-hydroxytryptophan, 18F-DOPA: 18F-fluoro-dihydroxyphenylalanin, 18F-FDG: 18F-fluoro-2-deoxy-d-glucose, 18F-FDG-6-P: 18F-fluoro-2-deoxy-d-glucose-6-phosphate, GLP-1: glucagon-like peptide 1, LAT: large amino acid transporter, VMAT: vesicular monoamine transporter. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions

Fig. 7 Results of somatostatin receptor scintigraphy presented in a Forest plot analysis. On the left side of this plot the reference of the study is mentioned, on the right side sensitivities from literature data are provided with their calculated confidence intervals and number of patients. Results are clustered per imaging indication. Within the different groups studies are clustered per tumor subtype and according to year of publishing. 95% CI: 95% Confidence Interval. Critical Reviews in Oncology / Hematology 2012 82, 213-226DOI: (10.1016/j.critrevonc.2011.05.006) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions